Parkinson's disease Market Will Reflect Significant Growth Prospects During the Study Period [2017-2030], Anticipates DelveInsight

DelveInsight's "Parkinson's Disease Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Parkinson's Disease, historical and forecasted epidemiology as well as the Parkinson's Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Parkinson's Disease market size was USD 1837.90 million in 2017 in the 7MM.  Among the 7 Major Markets, the United States accounted for the majority of the market size, with USD 941.13 million followed by Germany, which has the second-highest market size after the United States in 2017.

Some of the facts of the report

·         Parkinson's Disease total prevalent population in the 7MM countries was observed to be 1,608,367 in 2017 and is growing at a CAGR of 0.54% for the study period [2017–2028].

·         Parkinson's Disease total diagnosed prevalent population was 1,373,639 in 2017.

·         Parkinson's Disease diagnosed prevalent population was assessed to be the highest for the United States that accounts for 44.29% of the total patient pool among the 7MM countries.

View Report: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment

Request for Free sample Report: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

Key benefits of the report

1. Parkinson's Disease market report covers a detailed overview and comprehensive insight of the Parkinson's Disease Epidemiology and Parkinson's Disease market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Parkinson's Disease market report provides insights into the current and emerging Parkinson's Disease therapies.

3. Parkinson's Disease market report offers a global historical and forecasted market covering drug outreach in 7MM.

4. Parkinson's Disease market report provides an edge that will help in developing business strategies by understanding trends shaping and driving the Parkinson's Disease market.

"The age-specific prevalence data showed that the majority of the cases were diagnosed in the age-group of 65-84 years, followed by those aged 45-64 years in the 7MM countries."

View Report: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment

Get a free sample page : https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

There are currently no disease‐modifying drugs, but Parkinson's Disease treatments are used to offer major symptomatic relief of the motor symptoms. They offer little benefit clinically in terms of the nonmotor manifestations. The present Parkinson's Disease treatment options include surgery, medication, complementary and supportive therapies (such as diet, exercise, physical therapy, occupational therapy, and speech therapy). The approved medication therapies are categorized into seven groups that include Levodopa, Carbidopa‐levodopa infusion (Duodopa), Dopamine agonists, MAO B inhibitors, Catechol O‐methyltransferase (COMT) inhibitors, Anticholinergics and Amantadine. The drug to be used at the beginning of Parkinson's Disease treatment is either levodopa or a dopamine agonist. L‐Dopa, a natural precursor of dopamine that is transformed in the brain into dopamine.

Besides gene therapy, stem cell therapy have also shown a more effective Parkinson's Disease treatment option. Stem cell research in Parkinson's Disease is focusing on understanding nerve cells development and how healthy cells can be used to replace unhealthy brain cells. 

View Report: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment

Request for Free sample Report: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

The expected launch of emerging therapies is believed to create a positive impact on Parkinson's Disease market size in the upcoming years.

1.    Apomorphine Infusion

2.    Accordion Pill Carbidopa/Levodopa

3.    APL–130277

4.    P2B001

5.    IPX203

6.    LY03003

7.    ABBV‐951

8.    NTCELL Implantation

9.    Nilotinib

10.    VY‐AADC

And many others

The key Parkinson's Disease market players have the potential to create a significant positive shift in Parkinson's Disease Market Size. Some of the companies involved are:-

1.    US WorldMeds LLC

2.    Intec Pharma

3.    Sunovion Pharma

4.    Pharma Two B Ltd.

5.    Impax Laboratories

6.    Luye Pharma

7.    AbbVie

8.    Living Cell Technologies

9.    Novartis

10.   Neurocrine Biosciences

And many others

View Report: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment

Get a free demo of the report: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

Table of Contents 

1

Parkinson's Disease Key Insights

2

Executive Summary of Parkinson's Disease  

3

Parkinson's Disease Market Overview at a Glance

4

Parkinson's Disease Case Reports 

5

Parkinson's Disease Epidemiology and Patient Population

6

Country Wise-Epidemiology of Parkinson's Disease

6.1

The United States Epidemiology

6.2

EU5 Countries Epidemiology

6.2.1

Germany

6.2.2

France

6.2.3

Italy

6.2.4

Spain

6.2.5

The United Kingdom

6.3

Japan Epidemiology

7

Treatment and Management of Parkinson's Disease

8

Parkinson's Disease Unmet Needs

9

Parkinson's Disease Marketed Drugs

9.1

Istradefylline (KW-6002): Kyowa Kirin

9.2

Opicapone: BIAL

9.3

Gocovri: Adamas Pharmaceuticals

9.4

Xadago: Zambon SpA

9.5

Osmolex ER: Osmotica Pharmaceutical

9.6

Duopa (Duodopa, ABT-SLV187): AbbVie

9.7

Rytary: Impax Laboratories (Amneal Pharmaceuticals)

9.8

Inbrija: Acorda Therapeutics

9.9

Nuplazid: ACADIA Pharmaceuticals Inc.

10

Parkinson's Disease Emerging Drugs

10.1

Apomorphine Infusion: US WorldMeds LLC

10.2

Accordion Pill Carbidopa/Levodopa: Intec Pharma

10.3

P2B001: Pharma Two B Ltd.

10.4

IPX203: Impax Laboratories (Amneal Pharmaceuticals)

10.5

LY03003: Luye Pharma

10.6

ABBV-951: AbbVie

10.7

Allo iPS cell-derived dopamine neural progenitor: Sumitomo Dainippon Pharma

10.8

Solriamfetol (JZP-110): Jazz Pharmaceuticals

10.9

NBIb-1817 (VY-AADC): Neurocrine Biosciences/Voyager Therapeutics

10.10

AAV-GAD: MeiraGTx Limited

10.11

AXO-Lenti-PD (OXB-102): Axovant Sciences

10.12

ND0612: NeuroDerm

10.13

ITI-214: Intracellular Therapies

10.14

IRL752: Integrative Research Laboratories AB (IRLAB)

10.15

PR001: Prevail Therapeutics

10.16

ISC-hpNSC: International Stem Cell Corporation

11

7MM Parkinson's Disease Market Analysis

11.1

The United States Parkinson's Disease Market Size

11.2

EU-5 Parkinson's Disease Market Size

11.2.1

Germany Market Size

11.2.2

France Market Size

11.2.3

Italy Market Size

11.2.4

Spain Market Size

11.2.5

The United Kingdom Market Size

11.3

Japan Parkinson's Disease Market Size

12

Parkinson's Disease Market Drivers

13

Parkinson's Disease Market Barriers

14

SWOT Analysis of Parkinson's Disease

15

KOL Views

16

Parkinson's Disease Market Access and Reimbursement

17

Appendix

18

DelveInsight Capabilities

19

Disclaimer

20

About DelveInsight

 

Request for Deatiled TOC: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

Other Links:

 

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/
Connect With Us at:
LinkedIn | Facebook | Twitter

Get Free Sample Copy of Report at: https://www.delveinsight.com/sample-request/parkinsons-disease-market-size-analysis-treatment

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more